Walnut Hill Medical has appointed Chris Jordan as the new president of the Dallas-based provider of market access, DME, and preauthorization solutions.
The company, which rebranded last month from Pacific Therapy Access to Walnut Hill Medical, said Jordan brings a wealth of experience and leadership to Walnut Hill Medical, marking a significant milestone in the company’s ongoing growth.
“We are thrilled to welcome Chris Jordan to the Walnut Hill Medical family,” CEO Chris Hanna said in a statement. “His extensive experience and passion for healthcare innovation make him the ideal leader to steer our company into the future.”
Most recently, Jordan was a director of enterprise accounts for Abbott Cardiovascular where his team delivered consistent sales growth and won numerous awards, the company said.
Walnut Hill Medical said that Jordan has proven his expertise in leading teams, driving strategic initiatives, and delivering outstanding results in his 20 years in the medical device industry.
As president, Jordan will oversee all aspects of operations and strategy, ensuring that the company continues to meet the highest standards of quality and service, Walnut Hill Medical said.
“I am excited to join Walnut Hill Medical and grateful for the opportunity to help steward this incredible company.” Jordan said in a statement. “Walnut Hill Medical is dedicated to making a difference in patients’ lives and partnering with innovative medical device companies to expedite sales growth and product adoption. Together, we will continue delivering cutting-edge solutions to our customers and explore new opportunities for growth.”
Jordan joined Abbott in 2017 and became area director in January 2020. Before Abbott, he served in leadership roles at St. Jude Medical in Cardiovascular and Neuromodulation. He began his career in sales at Neuro Resource Group.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
-
Presented by TAMEST and Lyda Hill Philanthropies, the inaugural 2025 Hill Prizes recognize groundbreaking research by innovators in medicine, engineering, biological and physical sciences, and technology. Meet all five winners—and see how they'll use their $500,000 prizes to make game-changing "real-world impact" in each of their fields.
-
The $3.3 billion is coming to Texas under the federal Broadband Equity, Access, and Deployment Program. The deadline for Texas to submit its initial proposal for spending the funds is December 27—and the last day for public comment is today (Monday, December 4).
-
Jim Bruty joined the company in March as its chief operating officer, bringing more than two decades of commercial leadership within the orthopedic and spine technology industry.
-
Dallas-based Lyda Hill Philanthropies is donating 20,000 eclipse safety glasses, tabletop sun-spotter telescopes, telescope tripods and solar filters, binocular filters, smartphone sun photography adapters, and eclipse-themed books to Texas State Parks within the path of totality of the April 8 total solar eclipse.
